Delivery Order SPE2DR25D2206-SPE2DR26F9BB4
Award Date 11/10/25
Potential Completion Date 11/12/25
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,132.72 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The contract, awarded on November 6, 2025, with an ultimate completion date of November 7, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating open and competitive procurement. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,688.69 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on October 28, 2025, with an ultimate completion date of October 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,715.47 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. Issued on April 22, 2025, with completion targeted for April 23, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under a competitive award with no set-aside designation. The contract will be performed at...
- The Defense Logistics Agency awarded a $26,582.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The contract was competitively awarded with no set-aside designation and is set for completion by August 4, 2025. This delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a $22,946.07 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhaler medication used to treat chronic obstructive pulmonary disease. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of September 9, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,131.60 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 (60-count), a combination inhaler medication used to treat chronic obstructive pulmonary disease. Awarded on October 27, 2025, with an ultimate completion date of October 28, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $20,089.16 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination pulmonary medication supplied in a 60-dose inhaler. The contract was awarded on April 24, 2025, with an ultimate completion date of April 25, 2025, and employs firm fixed price terms with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,949.47 to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count units). This is a firm fixed-price delivery order with an ultimate completion date of November 10, 2025, classified as a child contract with no set-aside designation. The award represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,713.88 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, was issued under a firm fixed-price delivery order mechanism with no set-aside designation. This award represents a competitive procurement that leverages...
- The Defense Logistics Agency (DLA) awarded a $16,409.89 firm fixed price delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation medication used to treat chronic obstructive pulmonary disease. The award, issued on July 22, 2025, is a non-set-aside competitive procurement with an ultimate completion date of July 23, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...